Clovis Oncology Inc CLVS shares are trading higher by $2.15 at $14.50 in Wednesday's session. The battered biotech is moving off in sympathy with huge move higher in Tesaro Inc.
After a higher open, it dipped to $13.89 before rallying to $15.89. That marks the highest level for the issue since it peaked on June 9 at $15.89. Since making that high, it has drifted back.
The issue peaked back in September at $116.75 and fell all the way to $11.57 earlier this month.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in